MedTrace Logo

Role of Slowly Digesible Starch on Diabetes Risk Factors

NCT01708694 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 65

Last updated 2017-12-15

No results posted yet for this study

Summary

The purpose of this study is to determine the effect of a slowly digesting starch on gut bacteria, sugar and fat metabolism, hunger hormones, and body fat in people with pre-diabetes.

Conditions

Interventions

DIETARY_SUPPLEMENT

Amylose

One group of participants will consume a yogurt containing 45 g of amylose (the slowly digesting starch) for 3 months.

DIETARY_SUPPLEMENT

Amylopectin

The second group will consume a yogurt containing 45 g of a different starch called amylopectin (the "placebo") for 3 months.

Sponsors & Collaborators

  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

    collaborator NIH

  • Pennington Biomedical Research Center

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
35 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-08-31
Primary Completion
2016-06-30
Completion
2016-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01708694 on ClinicalTrials.gov